Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
5.750
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable
February 15, 2024
Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.
Via
InvestorPlace
5 Stocks to Buy to Invest Like Nvidia
February 15, 2024
Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker's methodology and focus on AI exposure.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 AI Stocks that Could be the Next Palantir
February 15, 2024
These niche AI stocks are using Palantir's ascent as a roadmap to market dominance in their respective fields.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Is Betting on SoundHound AI (SOUN) Stock
February 15, 2024
SOUN stock has been having a great last month, and a disclosure showing that Nvidia is betting on it, too, is sending SOUN even higher.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's Going On With Recursion Pharmaceuticals Stock On Thursday?
February 15, 2024
Recursion Pharmaceuticals' approach to drug discovery. NVIDIA's $75.9 million stake amplifies the impact of generative AI in identifying innovative treatments.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
A Glimpse Into The Expert Outlook On Recursion Pharmaceuticals Through 4 Analysts
January 17, 2024
Via
Benzinga
What's Going On With Recursion Pharmaceuticals Stock?
January 09, 2024
Via
Benzinga
Nvidia Is Betting Big on ARM Stock
February 15, 2024
Arm stock is up on Thursday after investors in the semiconductor company learned that graphics card company Nvidia holds a large stake in it.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
Nvidia Bolsters AI Leadership with Investment in Arm Holdings, Eyes Future Growth in Semiconductor Industry
February 15, 2024
Nvidia's investment portfolio includes stakes in Arm Holdings, SoundHound AI, and Recursion Pharmaceuticals. Despite failed acquisition, Arm's market valuation has soared to $130 billion. Significant...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Discloses Stakes In Arm, SoundHound AI, Nano-X And More
February 14, 2024
The AI chip leader revealed investments in its first-ever 13F SEC filing late Wednesday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Regulatory Compliance
Exposures
Artificial Intelligence
Legal
Regulatory
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
February 08, 2024
These two platform biotechs could revolutionize the field of biologically based products.
Via
The Motley Fool
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
February 07, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
February 07, 2024
They aren't all long shots, but they're all innovative.
Via
The Motley Fool
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
It's also important to consider their downsides.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
January 25, 2024
The widely followed growth stock investor is adding to some of her holdings this week.
Via
The Motley Fool
Altitude Lab Startups Raise Over $120M in Capital
January 24, 2024
Launches Fellowship Grant Opportunity for Early Career Entrepreneurs
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
January 17, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
January 15, 2024
These companies are still in the early innings of their growth potential.
Via
The Motley Fool
Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights
January 13, 2024
Nvidia provides artificial intelligence solutions for various markets, including the healthcare and automotive industries.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
These companies could stand out thanks to game-changing technology.
Via
The Motley Fool
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
January 09, 2024
Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.
Via
InvestorPlace
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
Recursion and NVIDIA will host an invite-only event on Wednesday, January 10, where Recursion will provide live demonstrations of LOWE, its new LLM-based software that can perform complex drug...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
January 04, 2024
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024
January 03, 2024
The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year.
Via
The Motley Fool
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
January 02, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.